En | De
Sie sind hier: Onkologie » Urologische Tumoren 11. Mai 2021
Urologische Tumoren
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Endokrine Organe
Gynäkologische Tumoren
Urologische Tumoren
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 6773  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 135442  
Association between sunlight exposure and risk of prostate cancer: a systematic review and meta-analysis.
Eur J Public Health
Yoon JG, Kim HB.
PMID: 33969413 [PubMed - as supplied by publisher]

Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma.
Front Mol Biosci
Zhan C, Wang Z, Xu C, Huang X, Su J, Chen B, Wang M, Qi Z, Bai P.
PMID: 33968978 [PubMed]

The Effect of Local Therapy on M1c Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Front Surg
Wang Z, Cao D, Wei W.
PMID: 33968976 [PubMed]

The Heterogeneous Metabolic Patterns of Ganglia in 68Ga-PSMA, 11C-choline, and 18F-FDG PET/CT in Prostate Cancer Patients.
Front Oncol
Shi Y, Wu JG, Xu L, Zhu Y, Wang Y, Huang G, Liu J, Chen R.
PMID: 33968772 [PubMed]

Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice.
Front Oncol
Roberto M, Botticelli A, Panebianco M, Aschelter AM, Gelibter A, Ciccarese C, Minelli M, Nuti M, Santini D, Laghi A, Tomao S, Marchetti P.
PMID: 33968762 [PubMed]

A Non-Invasive Scoring System to Differential Diagnosis of Clear Cell Renal Cell Carcinoma (ccRCC) From Renal Angiomyolipoma Without Visible Fat (RAML-wvf) Based on CT Features.
Front Oncol
Wang XJ, Qu BQ, Zhou JP, Zhou QM, Lu YF, Pan Y, Xu JX, Miu YY, Wang HQ, Yu RS.
PMID: 33968732 [PubMed]

The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
Front Oncol
Zhou Y, Wang X, Zhang W, Liu H, Liu D, Chen P, Xu D, Liu J, Li Y, Zeng G, Li M, Wu Z, Zhang Y, Wang X, DiSanto ME, Zhang X.
PMID: 33968730 [PubMed]

Extracellular vesicles in prostate cancer: a narrative review.
Transl Androl Urol
Hatano K, Fujita K.
PMID: 33968677 [PubMed]

Urinary extracellular vesicles: a rising star in bladder cancer management.
Transl Androl Urol
Urabe F, Kimura T, Ito K, Yamamoto Y, Tsuzuki S, Miki J, Ochiya T, Egawa S.
PMID: 33968676 [PubMed]

Narrative review of urinary glycan biomarkers in prostate cancer.
Transl Androl Urol
Hatakeyama S, Yoneyama T, Tobisawa Y, Yamamoto H, Ohyama C.
PMID: 33968674 [PubMed]

Application of metastatic biopsy based on "When, Who, Why, Where, How (4W1H)" principle in diagnosis and treatment of metastatic castration-resistance prostate cancer.
Transl Androl Urol
Liu Z, Wang L, Zhou Y, Wang C, Ma Y, Zhao Y, Tian J, Huang H, Wang H, Wang Y, Niu Y.
PMID: 33968660 [PubMed]

Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol Focus
Lardas M, Grivas N, Debray TPA, Zattoni F, Berridge C, Cumberbatch M, Van den Broeck T, Briers E, De Santis M, Farolfi A, Fossati N, Gandaglia G, Gillessen S, O'Hanlon S, Henry A, Liew M, Mason M, Moris L, Oprea-Lager D, Ploussard G, Rouviere O, Schoots IG, van der Kwast T, van der Poel H, Wiegel T, Willemse PP, Yuan CY, Grummet JP, Tilki D, van den Bergh RCN, Lam TB, Cornford P, Mottet N.
PMID: 33967010 [PubMed - as supplied by publisher]

Digital Medicine in Men with Advanced Prostate Cancer - A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment.
Clin Oncol (R Coll Radiol)
Appleyard SE, Larkin MJW, Stewart EM, Minton O, Gilbert DC.
PMID: 33966948 [PubMed - as supplied by publisher]

Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: An international wide cohort study.
Eur J Surg Oncol
De Nunzio C, Franco A, Simone G, Tuderti G, Anceschi U, Brassetti A, Daneshmand S, Miranda G, Desai MM, Gill I, Abol-Enein H, Molinaro E, Nacchia A, Lombardo R, Leonardo C, Tubaro A.
PMID: 33966945 [PubMed - as supplied by publisher]

Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: The Triumph of Radiobiology.
Rev Recent Clin Trials
Kougioumtzopoulou A, Platoni K, Zygogianni A, Kounadis G, Syrigos KN, Psyrri A, Bamias A, Kelekis N, Kouloulias V.
PMID: 33966623 [PubMed - as supplied by publisher]

The prognostic value of sarcopenia in patients with prostate cancer: a systematic review.
Curr Opin Urol
Jahrreiss V, Laukhtina E, D'Andrea D, Shariat SF.
PMID: 33965982 [PubMed - as supplied by publisher]

Part I. Health-related quality of life in bladder cancer patients: general and cancer-specific instruments.
Curr Opin Urol
Zimmermann K, Mostafaei H, Heidenreich A, Schmelz HU, Shariat SF, Mori K.
PMID: 33965980 [PubMed - as supplied by publisher]

Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysis.
Curr Opin Urol
Quhal F, Mori K, Remzi M, Fajkovic H, Shariat SF, Schmidinger M.
PMID: 33965978 [PubMed - as supplied by publisher]

Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatment.
World J Urol
Alanee S, Sana S, El-Zawahry A, Peabody J, Pearce T, Adams N, Deebajah M, Crabtree J, Delfino K, McVary K, Robinson K, Rao K.
PMID: 33966128 [PubMed - as supplied by publisher]

Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells.
Cell Death Discov
Shuvalov O, Kizenko A, Petukhov A, Fedorova O, Daks A, Barlev N.
PMID: 33966049 [PubMed]

   Artikel 1 - 20 / 135442    Seite 1 von 6773  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.



mehr >>


Sky right 1